The knowledge emerging from our research and demonstration initiatives provides the healthcare industry with innovative ways to think about improving leadership, enhancing organizational performance, understanding international market trends, and more. The result is a new generation of healthcare leaders equipped with the knowledge and management tools, insights, and expertise to achieve new standards of excellence. 

National Healthcare Leadership Survey

The window to participate in the 2022 survey is now closed. Please contact if your organization is interested in participating in 2024. 

Designed to point all organizations toward practices that are firmly grounded in sound scientific principles and the best available evidence for effectiveness, and to recognize high-performing organizations. 


The goal of the NCHL’s National Health Leadership Survey is to enable hospitals and healthcare systems to compare their leadership development efforts with evidence‐based best practices, benchmark their leadership practices in twelve different leadership dimensions, and monitor improvements over time. The survey also enables NCHL to evaluate the rate of adoption of evidence-based leadership best practices in the field and to study the relationship of adoption of specific leadership practices to organizational performance. The results of this survey culminate in the Best Organizations for Leadership Development (BOLD) award.  

Survey Frequently Asked Questions

Purpose of the survey and why your participation is critical:

The goal of the NCHL’s National Healthcare Leadership Survey is to enable hospitals and healthcare systems to compare their leadership development efforts with evidence‐based best practices, benchmark their leadership practices in twelve different leadership dimensions, and monitor improvements over time. The survey also enables NCHL to evaluate the rate of adoption of evidence-based leadership best practices in the field and to study the relationship of adoption of specific leadership practices to organizational performance. The results of this survey culminate in the Best Organizations for Leadership Development (BOLD) award at the NCHL All-Member Conference in November 2022.

Why should your organization participate in the survey?

By completing the survey, participating organizations are able to compare their approaches to leadership development to evidence-based practice as well as other health systems using the customized scorecard generated from survey responses.

The survey is designed to help your health systems strengthen their capacity to develop your leaders so they are best prepared to help fulfill your organization’s mission. The survey is revised every two years to continuously reflect the most current state-of-the-science in leadership development best practices. Recent peer-reviewed research using the scorecard has validated the impact of these practices on numerous organizational outcomes, including significant associations with hospital operating margins as well as patient experience (HCAHPS) scores.

The survey will launch on June 1, 2022. Organizations must REGISTER by May 13, 2022, in order to receive a unique survey link in order to participate. Organizations will only receive one unique link, sent to one primary contact. Please assure only one primary contact for your organization uses this registration form. The survey link for your organization, however, may be shared internally with your colleagues for ease of completing the survey. 

By filling out the registration form you are confirming that your organization would like to participate in the 2022 survey. After filling out this form you can expect to receive a personalized link the first week of June 2022 to participate in the National Healthcare Leadership Survey. Prior to the launch of the survey, you will also receive additional communications on how best to prepare for the survey completion and what to expect if your organization is ranked as a BOLD award recipient. 

The Best Organizations for Leadership Development (BOLD) award is the culmination of NCHL’s National Healthcare Leadership Survey, which is designed to point all organizations toward practices that are firmly grounded in sound scientific principles and best available evidence for effectiveness and to recognize high-performing organizations. 

The history of the National Healthcare Leadership Survey and BOLD:

NCHL rolled out its Leadership Survey in 2007, 2010, 2014, 2016, and in 2020.


In 2014, we used the results from a total of 103 hospitals and health systems to recognize 19 Best Organizations in Leadership Development (BOLD). With support from Cielo Healthcare in 2016, a new group of hospitals and health systems was recognized at the 2016 BOLD organizations. In 2020, the process was repeated and 10 BOLD organizations were recognized.


For the past eight years, prestigious healthcare organizations, like yours, from across the country have participated in the survey and the top achievers have been acknowledged with a Best Organizations for Leadership Development (BOLD) award for their dedication and work.

Survey Insights

The 2020 National Healthcare Leadership survey contained questions within 12 dimensions.

Every organization which completes the survey receives a personalized scorecard.

The NCHL Leadership Development Scorecard provides feedback on your organization’s leadership development practices compared to participating health systems from across the country. The Scorecard provides feedback on 12 interdependent dimensions that have demonstrated an impact on the effectiveness of leadership development systems. The maximum score, overall and in each dimension, is 100. Weightings are applied to help balance expected differences in the unique contribution of specific dimensions to overall effectiveness.


Centura Health

Children’s Hospital of Los Angeles

Children’s Health System of Texas

Cleveland Clinic

Cone Health

Henry Ford Health System

Intermountain Healthcare

Tampa General Hospital

University of Texas MD Anderson Cancer Center


NCHL Health Leadership Competency Model 3.0™

The NCHL Health Leadership Competency Model™ was developed to provide the field with a comprehensive, validated competency model that will be suitable as the foundation for a breadth of leadership assessment and development applications. To ensure relevance to leaders from across disciplines, the Model was developed and validated utilizing interdisciplinary subject matter experts, and was refined in collaboration with industrial and educational psychologists. 

USCIPP Business Intelligence and International Market Analysis

USCIPP is uniquely positioned to combine its annual benchmarking data with up-to-date economic, healthcare, and political information to provide comprehensive analyses on a range of topics. The portfolio and direction of USCIPP’s business intelligence work evolve as Premium members strategically look to the future and make critical decisions for their programs. 


Premium members have expressed that USCIPP’s business intelligence work products have been used to inform specific business plans and international marketing, staffing, and business development decisions. USCIPP’s major business intelligence and international market analysis initiatives and deliverables are outlined below. 

To date, USCIPP has released long-form market reports for Brazil, Canada, China, Cayman Islands, Colombia, Dominican Republic, Ecuador, India, Kuwait, Mexico, Qatar, Saudi Arabia, United Arab Emirates, and Vietnam. The market reports provide a comprehensive and deep analysis of each country’s economic, political, and healthcare environment through the lens of opportunities for international healthcare collaborations and outbound medical travel.

The goal of the USCIPP Monthly International Healthcare Digest is to provide a broad understanding of the current international healthcare market. Each newsletter provides recent updates on shifting international market dynamics, with a focus on new global collaborations, international travel trends, political and economic developments in key countries, international insurance news, developments in cross-border telemedicine and remote second opinions, and more. 

Updated on a monthly basis, the USCIPP International Healthcare Collaborations Map is an interactive representation of all known international healthcare collaborations. It uses a project classification typology that was developed by the USCIPP team with input from our member organizations. This unique tool enables users to better understand the current players and projects in international markets of interest. (Note that the map is available to all Premium USCIPP members and USCIPP organizational affiliates as a standalone app outside of the Qlik Sense dashboard environment. Corporate members may access the map if they choose the Premium International Market Insights Dashboard as part of the “personalized experience” portion of their benefits, as the map is embedded in this dashboard.) 

This Qlik Sense dashboard contains all of the latest news compiled from our monthly digests, country-specific economic information, and healthcare data. The USCIPP International Healthcare Collaborations Map is embedded within and included as part of this dashboard. (Note that all Premium USCIPP members and USCIPP organizational affiliates are entitled to a Qlik Sense license as part of their membership, but members must proactively request access. Corporate members may access the Premium International Market Insights Dashboard if they choose it as part of the “personalized experience” portion of their benefits.)  

The USCIPP International Insurance Database offers USCIPP members insights into the international private medical insurance landscape in key international markets. It identifies major insurers offering international coverage options that include the United States. The database also includes information about relevant brokers and third-party administrators. The USCIPP Benchmarking & Research Subcommittee chooses the markets included in the database. Examples include the Cayman Islands, Canada, Mainland China, Mexico, Saudi Arabia, and more. Additional countries are added to the database as the USCIPP team completes new, long-form, international market reports. 

USCIPP Annual Benchmarking Survey of International Programs in the US

USCIPP’s Annual Benchmarking Survey of International Programs in the US surveys USCIPP’s member hospitals and health systems with established international programs. Recognizing our members comprise most (but not all) US hospital and health systems with established international health programs, this benchmarking survey is best considered as a lower bound for the actual size of the US market.


The goal of this survey is to allow respondents to benchmark their international program operations against those at peer institutions through the data and insights garnered from this report. Due to the diverse group of member organizations, USCIPP’s survey is also able to distinguish pediatric versus adult services, which permits even stronger benchmarking capabilities. The annual USCIPP member survey collected information about services offered, financial metrics, operational metrics, and patient volumes. Additionally, the survey results provide insights into international program structures and geographic regions of home residence for patients traveling to the US for care. In-depth data and our full benchmarking reports are available to USCIPP’s member organizations.  

USCIPP International Patient Experience Initiative

In 2016, USCIPP members identified the development of standardized metrics to measure international patient experience and satisfaction that can be benchmarked across organizations as a high-priority need for the consortium. USCIPP partnered with Rush University’s Center for the Advancement of Healthcare Value (CAHV) to develop the survey instrument, methodology, administration platform, and database necessary to launch this initiative. USCIPP formally launched the initiative in April 2019. Since the official launch, participating USCIPP members have collectively surveyed thousands of international patients. The benefits that USCIPP members gain through their participation in this initiative include operational insights based on feedback gathered from international patients and their families results that may be benchmarked against trends at other participating organizations, peer discussions via monthly committee meetings, and methodologies specifically designed for international patients. 

The USCIPP International Patient Experience Initiative participation fee is $3,000 annually per USCIPP member. A Qlik Sense license will be necessary for participants to have access to the project’s patient experience data dashboard. This environment allows for members to generate customized reports—including cross-organizational benchmarking analyses of survey results—as well as integration with USCIPP’s annual benchmarking survey data.


Participating organizations will send the survey to their respective international patients who meet the criteria of eligibility. The administration protocol calls for three attempts to collect a response from the patient once the patient has completed medical care at the respective organization. Data are uploaded monthly into a custom-built dashboard that allows USCIPP members to run customized reports based on filterable criteria.

In order to participate, USCIPP members must agree to: 


• Secure institutional access to REDCap, as REDCap will be required to conduct patient satisfaction surveys through members’ own institutional REDCap accounts

• Commit a primary representative from their organization to participate in the International Patient Experience Committee, including monthly calls and ongoing related activities

• Maintain accurate records and administer the survey according to the guidelines and protocols set forth by the International Patient Experience Committee

• Send de-identified, individual-level results data to USCIPP on a monthly basis

• Acquire a license to Qlik Sense through USCIPP to have access to the dashboard if one has not already been requested

• Support the International Patient Experience Initiative with timely payment of the project participation fee, which is due to NCHL within 30 days of receipt of the invoice

• Advise on design and collection of survey data

• Program REDCap in four languages in addition to English (Spanish, Arabic, Portuguese, and Simplified Chinese)

• Program individual members’ REDCap data dictionaries with a customized cover letter

• Quality test REDCap to ensure functionality

• Provide ongoing support to members with REDCap, survey administration, and methodology, as needed

• Research, test, and sort out alternative methodologies to survey patients using REDCap according to practices and general hospital requirements regarding the use of communication apps to survey patients

• Organize monthly conference calls for committee members

• Arrange for an outside service to translate the questionnaire into Spanish, Arabic, Portuguese, and Simplified Chinese

• Collect, inspect, clean, and compile data (not to include any protected health information) from USCIPP members for use in Qlik Sense

• Upload data on a monthly basis to the Qlik Sense dashboard

• Provide an annual year-in-review report 

Participants in the USCIPP International Patient Experience Initiative engage in the sharing of materials, best practices, and data across peer organizations. Participants mutually agree to hold entirely confidential the data or information received by them in connection with participation in the USCIPP International Patient Experience Initiative. If requested, NCHL agrees to execute and be bound by a business associate agreement.


Data collected through the USCIPP International Patient Experience Initiative will be stored on a secure drive owned by NCHL and the Qlik Sense data dashboard platform. Raw data are only available to internal NCHL staff. USCIPP agrees that:


• it will keep and maintain all member information in strict confidence, using such degree of care as is appropriate to avoid unauthorized access, use, or disclosure;

• it will not report individual member information and that only aggregated information will be reported without members’ prior written consent; and

• it will not directly or indirectly disclose member information to any person other than its authorized employees/authorized persons (including any subcontractors, agents, outsourcers, or auditors) without express written consent from the member.


All NCHL staff who will have access to the patient experience data will sign a legal confidentiality agreement, a copy of which will be provided upon request.

USCIPP International Telemedicine & RSO Due Diligence Initiative

In 2019, USCIPP launched an initiative focused on conducting legal due diligence related to the cross-border delivery of international telemedicine and remote second opinions (RSOs). The cost of having local counsel evaluate legal issues related to the delivery of telemedicine and RSOs in a new country/jurisdiction can be very high – sometimes $20,000 or more for a single market. Given the significant fees required to commission this kind of work, USCIPP’s members have developed a mechanism that allows for hospitals to share in the costs of conducting legal assessments regarding the delivery of telemedicine and RSOs in countries/jurisdictions of high interest to multiple members. This enables USCIPP members to complete a large amount of their legal due diligence process for numerous countries/jurisdictions at a substantial discount vs. what it would cost for a single institution to do the work alone.


After polling the broader membership and consulting with experts in law, telemedicine, and international business at several prominent member organizations, USCIPP developed a request for proposal (RFP) to contract for legal services to evaluate cross-border telemedicine and RSO services in a number of different markets chosen by USCIPP members. The RFP was sent to multiple international law firms. Hogan Lovells—a large, global law firm with deep experience in this area—was ultimately selected as the organization that submitted the strongest proposal. USCIPP and its member hospitals developed a standardized matrix that is used to analyze each market’s cross-border telemedicine and RSO legal/regulatory landscape. 


The final deliverables address legal issues related to the provision of telemedicine and RSOs in these markets. The resultant documents are meant to inform and empower individual institutions’ business and legal teams to develop tailored models of care with appropriate legal documentation. To date, USCIPP has commissioned reports for the following markets:  

• Canada: Province of Ontario (December 2019)

• Canada: Province of Alberta (February 2020)

• Hong Kong (December 2019)

• Macau (December 2019)

• Mexico (UPDATED April 2022)

• People’s Republic of China (Mainland China) (UPDATED September 2021)

• Republic of China (Taiwan) (January 2020)

• Saudi Arabia (UPDATED August 2022)

• United Arab Emirates (UPDATED December 2021)

• United Kingdom (UPDATED April 2021)

• Bahrain (April 2020)

• Bermuda (May 2020)

• Brazil (UPDATED May 2022)

• Canada: Province of British Columbia (July 2020)

• Canada: Province of Québec (July 2020)

• Colombia (May 2020)

• Dominican Republic (May 2020)

• Ecuador (May 2020)

• Kuwait (UPDATED September 2021)

• Qatar (UPDATED September 2021)

• Costa Rica (December 2020)

• India (November 2020)

• Panama (November 2020)

• Peru (December 2020)

Contact our Research Team